Ahrens Investment Partners’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $42.2K | Buy |
+8,000
| New | +$42.2K | 0.02% | 355 |
|
|
2022
Q3 | – | Sell |
-8,000
| Closed | -$32K | – | 662 |
|
|
2022
Q2 | $32K | Buy |
8,000
+500
| +7% | +$2K | 0.01% | 411 |
|
|
2022
Q1 | $37K | Hold |
7,500
| – | – | 0.01% | 458 |
|
|
2021
Q4 | $52K | Buy |
+7,500
| New | +$52K | 0.02% | 398 |
|
|
2020
Q1 | – | Sell |
-10,500
| Closed | -$41K | – | 158 |
|
|
2019
Q4 | $41K | Buy |
+10,500
| New | +$41K | 0.02% | 166 |
|